Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2020English

Αvβ3-Integrin Regulates PD-L1 Expression and Is Involved in Cancer Immune Evasion

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Immune Checkpoint Inhibition in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Microparticles From Tumors Exposed to Radiation Promote Immune Evasion in Part by PD-L1

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy